360 related articles for article (PubMed ID: 23187048)
21. Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Clinical Trial.
Davis JM; Shenberger J; Terrin N; Breeze JL; Hudak M; Wachman EM; Marro P; Oliveira EL; Harvey-Wilkes K; Czynski A; Engelhardt B; D'Apolito K; Bogen D; Lester B
JAMA Pediatr; 2018 Aug; 172(8):741-748. PubMed ID: 29913015
[TBL] [Abstract][Full Text] [Related]
22. An Initiative to Improve the Quality of Care of Infants With Neonatal Abstinence Syndrome.
Grossman MR; Berkwitt AK; Osborn RR; Xu Y; Esserman DA; Shapiro ED; Bizzarro MJ
Pediatrics; 2017 Jun; 139(6):. PubMed ID: 28562267
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of a clinical pathway with methadone treatment protocol for treatment of neonatal abstinence syndrome following in utero drug exposure to substances of abuse*.
Bhatt-Mehta V; Ng CM; Schumacher RE
Pediatr Crit Care Med; 2014 Feb; 15(2):162-9. PubMed ID: 24141658
[TBL] [Abstract][Full Text] [Related]
24. A prospective study on buprenorphine use during pregnancy: effects on maternal and neonatal outcome.
Kahila H; Saisto T; Kivitie-Kallio S; Haukkamaa M; Halmesmäki E
Acta Obstet Gynecol Scand; 2007; 86(2):185-90. PubMed ID: 17364281
[TBL] [Abstract][Full Text] [Related]
25. Neonatal Abstinence Syndrome: Update on Diagnostic and Therapeutic Strategies.
Raffaeli G; Cavallaro G; Allegaert K; Wildschut ED; Fumagalli M; Agosti M; Tibboel D; Mosca F
Pharmacotherapy; 2017 Jul; 37(7):814-823. PubMed ID: 28519244
[TBL] [Abstract][Full Text] [Related]
26. Neurodevelopmental Outcomes of Neonates Randomized to Morphine or Methadone for Treatment of Neonatal Abstinence Syndrome.
Czynski AJ; Davis JM; Dansereau LM; Engelhardt B; Marro P; Bogen DL; Hudak ML; Shenberger J; Wachman EM; Oliveira EL; Lester BM
J Pediatr; 2020 Apr; 219():146-151.e1. PubMed ID: 31987653
[TBL] [Abstract][Full Text] [Related]
27. [Is buprenorphine a potential alternative to methadone for treating pregnant drug users? Inventory of clinical data in the literature].
Loustauneau A; Auriacombe M; Daulouede JP; Tignol J
Ann Med Interne (Paris); 2002 Nov; 153(7 Suppl):2S31-6. PubMed ID: 12518080
[TBL] [Abstract][Full Text] [Related]
28. Emerging therapies for the treatment of neonatal abstinence syndrome.
Frazier LM; Bobby LE; Gawronski KM
J Matern Fetal Neonatal Med; 2022 Mar; 35(5):987-995. PubMed ID: 32146833
[TBL] [Abstract][Full Text] [Related]
29. [A multidisciplinary approach is necessary in the neonatal withdrawal syndrome].
Leeuwenburgh-Pronk WG; de Vries MC; Clement-de Boers A
Ned Tijdschr Geneeskd; 2006 Apr; 150(14):761-5. PubMed ID: 16649391
[TBL] [Abstract][Full Text] [Related]
30. Maternal Substance Use and Neonatal Abstinence Syndrome: A Descriptive Study.
McQueen KA; Murphy-Oikonen J; Desaulniers L
Matern Child Health J; 2015 Aug; 19(8):1756-65. PubMed ID: 25656717
[TBL] [Abstract][Full Text] [Related]
31. The impact of infant feeding method on neonatal abstinence scores of methadone-exposed infants.
McQueen KA; Murphy-Oikonen J; Gerlach K; Montelpare W
Adv Neonatal Care; 2011 Aug; 11(4):282-90. PubMed ID: 22123351
[TBL] [Abstract][Full Text] [Related]
32. [Opiate addiction in gravidity - consequences for the newborn. Results of an interdisciplinary treatment concept].
Rohrmeister K; Bernert G; Langer M; Fischer G; Weninger M; Pollak A
Z Geburtshilfe Neonatol; 2001; 205(6):224-30. PubMed ID: 11745008
[TBL] [Abstract][Full Text] [Related]
33. Review of the assessment and management of neonatal abstinence syndrome.
Bagley SM; Wachman EM; Holland E; Brogly SB
Addict Sci Clin Pract; 2014 Sep; 9(1):19. PubMed ID: 25199822
[TBL] [Abstract][Full Text] [Related]
34. Neonatal abstinence syndrome: strategies for care of the drug-exposed infant.
Greene CM; Goodman MH
Neonatal Netw; 2003; 22(4):15-25. PubMed ID: 12934746
[TBL] [Abstract][Full Text] [Related]
35. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.
Jones HE; Johnson RE; Jasinski DR; O'Grady KE; Chisholm CA; Choo RE; Crocetti M; Dudas R; Harrow C; Huestis MA; Jansson LM; Lantz M; Lester BM; Milio L
Drug Alcohol Depend; 2005 Jul; 79(1):1-10. PubMed ID: 15943939
[TBL] [Abstract][Full Text] [Related]
36. Neonatal Abstinence Syndrome: Review of Epidemiology, Care Models, and Current Understanding of Outcomes.
MacMillan KDL
Clin Perinatol; 2019 Dec; 46(4):817-832. PubMed ID: 31653310
[TBL] [Abstract][Full Text] [Related]
37. Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey.
Sarkar S; Donn SM
J Perinatol; 2006 Jan; 26(1):15-7. PubMed ID: 16355103
[TBL] [Abstract][Full Text] [Related]
38. [Neonatal seizures, buprenorphine abstinence syndrome, and substitutive treatment with morphine].
Dahan S; Elefant E; Girard I; Azcona B; Champion V; Mitanchez D
Arch Pediatr; 2011 Mar; 18(3):287-90. PubMed ID: 21269813
[TBL] [Abstract][Full Text] [Related]
39. Pharmacotherapy for Neonatal Abstinence Syndrome: Choosing the Right Opioid or No Opioid at All.
McPherson C
Neonatal Netw; 2016; 35(5):314-20. PubMed ID: 27636696
[TBL] [Abstract][Full Text] [Related]
40. Neonatal opioid withdrawal syndrome.
Sutter MB; Leeman L; Hsi A
Obstet Gynecol Clin North Am; 2014 Jun; 41(2):317-34. PubMed ID: 24845493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
